Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma
PD-L1(阿特珠单抗)和VEGF(贝伐珠单抗)联合阻断治疗晚期恶性腹膜间皮瘤的疗效、安全性和生物标志物分析
期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-21-0331
Raghav, Kanwal; Liu, Suyu; Overman, Michael J; Willett, Anneleis F; Knafl, Mark; Fu, Szu-Chin; Malpica, Anais; Prasad, Seema; Royal, Richard E; Scally, Christopher P; Mansfield, Paul F; Wistuba, Ignacio I; Futreal, Andrew P; Maru, Dipen M; Solis Soto, Luisa M; Parra Cuentas, Edwin R; Chen, Honglei; Villalobos, Pamela; Verma, Anuj; Mahvash, Armeen; Hwu, Patrick; Cortazar, Patricia; McKenna, Edward; Yun, Cindy; Dervin, Shannon; Schulze, Katja; Darbonne, Walter C; Morani, Ajaykumar C; Kopetz, Scott; Fournier, Keith F; Woodman, Scott E; Yao, James C; Varadhachary, Gauri R; Halperin, Daniel M